AGRP (54-82)

AGRP (54-82)

AGRP (54-82)

AGRP (54-82)

AGRP (54-82)

AGRP (54-82) is a synthetic peptide fragment corresponding to the C-terminal portion (residues 54-82) of the full-length human Agouti-Related Protein (AGRP). This research-grade peptide represents a structurally disordered, cysteine-rich region of AGRP, distinct from the N-terminal active core. It serves as a critical control, epitope mapping tool, or structural probe in studies of AGRP biosynthesis, folding, and receptor interaction, complementing research using the active AGRP (25-51) fragment.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 AGRP (54-82)
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
 C₁₄₁H₂₃₈N₄₆O₃₂S
Molecular Weight
 3022.76 g/mol
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥5 mg/ml), DMSO, and dilute aqueous buffers.

Endotoxin< 1.0 EU/mg
Biological Activity
Potent antagonist of melanocortin receptors (MC1R, MC3R, MC4R, MC5R); modulates energy homeostasis, feeding behavior, and pigmentation; used as a research tool for metabolic and neurobiology studies
Storage Conditions
Store at -20°C to -80°C in a dry, dark, sealed environment; avoid repeated freeze-thaw cycles; aliquot for single use.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Unlike the N-terminal fragment (AGRP 25-51), the C-terminal AGRP (54-82) fragment itself lacks the structured, bioactive loop responsible for high-affinity antagonism at melanocortin receptors (MC3R/MC4R). Therefore, its primary utility is not direct receptor modulation. Its mechanisms relate to its role in the full-length protein:
  1. Structural Role in Full-Length AGRP: In the native protein, this cysteine-rich domain is involved in forming disulfide bonds that stabilize the overall structure, potentially influencing the presentation and folding of the active N-terminal loop.

  2. Research Probe: It is primarily used as a negative control or specificity control in experiments testing the effects of the active AGRP fragment. Its lack of receptor activity confirms that observed biological effects are due to the specific active site, not non-specific peptide interactions.

  3. Antigenic Epitope: The sequence can be used to generate antibodies specific to the C-terminus of AGRP for detection, localization, or quantification studies of the prohormone or its processing.


2.PRODUCT INDICATIONS

This product is indicated for specialized, foundational research in neuropeptide biochemistry and molecular pharmacology. Key applications include:
  • As a critical negative control in experiments investigating the effects of AGRP on feeding behavior, energy homeostasis, or melanocortin receptor signaling. Its use validates that effects are specific to the active receptor-binding domain.

  • In studies of AGRP protein structure, folding, and disulfide bond formation.

  • For epitope mapping and antibody generation to distinguish between different regions of the AGRP protein or its cleavage products.

  • In research on the post-translational processing and maturation of the AGRP prohormone.

  • As a tool in assay development and validation (e.g., ELISA, Western blot) to ensure specificity for the active fragment versus other regions.


3.CLINICAL EFFICACY OF PRODUCT

AGRP (54-82) itself has no direct clinical efficacy as a therapeutic or diagnostic. Its immense value is in ensuring scientific rigor and validity in preclinical research. By providing a well-defined inactive fragment, it allows researchers to:
  • Definitively attribute physiological effects (like increased food intake) to the specific antagonism of melanocortin receptors by the active AGRP core, strengthening the evidence base.

  • Avoid misinterpretation of data that could arise from non-specific effects of peptide administration.

  • Support the high-quality, reproducible science that underpins translational drug discovery. The clear distinction between active and inactive regions of AGRP was crucial for rationally designing melanocortin receptor-targeted drugs (like setmelanotide).


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.